Stryker (SYK) Free Cash Flow Growth (1y) (2010 - 2026)
Stryker (SYK) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | -14.34% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 19.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.12% |
| Mar 31, 2026 | 226.77% |
| Dec 31, 2025 | 12.61% |
| Sep 30, 2025 | 3.76% |
| Jun 30, 2025 | 92.93% |
| Mar 31, 2025 | 243.24% |
| Dec 31, 2024 | 20.39% |
| Sep 30, 2024 | 44.57% |
| Jun 30, 2024 | -10.26% |
| Mar 31, 2024 | -88.25% |
| Dec 31, 2023 | 69.69% |
| Sep 30, 2023 | 20.11% |
| Jun 30, 2023 | 38.86% |
| Mar 31, 2023 | 275.00% |
| Dec 31, 2022 | 2.64% |
| Sep 30, 2022 | -6.48% |
| Jun 30, 2022 | -50.00% |
| Mar 31, 2022 | -77.24% |
| Dec 31, 2021 | -25.93% |
| Sep 30, 2021 | 5.66% |